0001144204-16-110884.txt : 20160630
0001144204-16-110884.hdr.sgml : 20160630
20160630171139
ACCESSION NUMBER: 0001144204-16-110884
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160629
FILED AS OF DATE: 20160630
DATE AS OF CHANGE: 20160630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akari Therapeutics Plc
CENTRAL INDEX KEY: 0001541157
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981034922
STATE OF INCORPORATION: X0
BUSINESS ADDRESS:
STREET 1: 24 WEST 40TH STREET
STREET 2: 8TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: (646) 350-0702
MAIL ADDRESS:
STREET 1: 24 WEST 40TH STREET
STREET 2: 8TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Celsus Therapeutics Plc.
DATE OF NAME CHANGE: 20130621
FORMER COMPANY:
FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC
DATE OF NAME CHANGE: 20120201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cohen Mark S
CENTRAL INDEX KEY: 0001622779
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36288
FILM NUMBER: 161743871
MAIL ADDRESS:
STREET 1: C/O CELSUS THERAPEUTICS PLC
STREET 2: 24 WEST 40TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10018
4
1
v443329_4.xml
OWNERSHIP DOCUMENT
X0306
4
2016-06-29
0
0001541157
Akari Therapeutics Plc
AKTX
0001622779
Cohen Mark S
C/O AKARI THERAPEUTICS PLC
24 WEST 40TH STREET, 8TH FLOOR
NEW YORK
NY
10018
1
0
0
0
Options to Purchase Ordinary Shares
0.1454
2016-06-29
4
A
0
1300000
0
A
2026-06-29
Ordinary Shares
1300000
1300000
D
All shares underlying the options will vest in full on the date of the Issuer's 2017 Annual General Meeting and expire ten years from issuance.
/s/ Dov Elefant, as attorney-in-fact
2016-06-30